Ledger.Open graph →
SEC Form D · filed March 3, 2025

Chimeron Bio Corp

Offering
—
Sold
$13.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Afshin Safavi · Philadelphia, PADirectorAntonin De Fougerolles · Philadelphia, PADirectorKevin Heyeck · Philadelphia, PAExec · DirectorMonica Coleman · Philadelphia, PAExecRyan Clinton · Memphis, TNDirectorEdward H. O'Donnell · Houston, TXDirectorMonica Coleman · Philadelphia, PAExecCatalyst Impact Partners, Corp · Cambridge, MAExec · DirectorJames N. Falbe · Chandler, AZExec · DirectorDennis Bethel · FRIANT, CADirectorChris Justin · NEW ORLEANS, LADirectorAdam Roter · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗